Postoperative Adjuvant Chemotherapy or Chemoradiation versus Surgery alone for Thoracic Pathological Node Positive Esophageal Cancer: A Propensity Score-Matched Analysis (APEC Study 2)
机构：[1]Department of Radiation Oncology, Sichuan Cancer Hospital& Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China,四川省人民医院四川省肿瘤医院[2]Thoracic Surgery Department, Sichuan Cancer hospital institute/ Sichuan Cancer Center/School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院
第一作者机构：[1]Department of Radiation Oncology, Sichuan Cancer Hospital& Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China,
推荐引用方式(GB/T 7714)：
Wang Q.,Li T.,Han Y.,et al.Postoperative Adjuvant Chemotherapy or Chemoradiation versus Surgery alone for Thoracic Pathological Node Positive Esophageal Cancer: A Propensity Score-Matched Analysis (APEC Study 2)[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2019,105(1):S129-S129.doi:10.1016/j.ijrobp.2019.06.111.
APA：
Wang, Q.,Li, T.,Han, Y.,Li, Q.,Peng, L....&Lang, J..(2019).Postoperative Adjuvant Chemotherapy or Chemoradiation versus Surgery alone for Thoracic Pathological Node Positive Esophageal Cancer: A Propensity Score-Matched Analysis (APEC Study 2).INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,105,(1)
MLA：
Wang, Q.,et al."Postoperative Adjuvant Chemotherapy or Chemoradiation versus Surgery alone for Thoracic Pathological Node Positive Esophageal Cancer: A Propensity Score-Matched Analysis (APEC Study 2)".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 105..1(2019):S129-S129
医学